SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-19-000791
Filing Date
2019-02-28
Accepted
2019-02-28 16:50:53
Documents
70
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2237755z10-k.htm 10-K 1584641
2 EX-10.12 a2237755zex-10_12.htm EX-10.12 70122
3 EX-10.13 a2237755zex-10_13.htm EX-10.13 79689
4 EX-10.16 a2237755zex-10_16.htm EX-10.16 594112
5 EX-23.1 a2237755zex-23_1.htm EX-23.1 6151
6 EX-31.1 a2237755zex-31_1.htm EX-31.1 7873
7 EX-31.2 a2237755zex-31_2.htm EX-31.2 7904
8 EX-32.1 a2237755zex-32_1.htm EX-32.1 4497
15 G933571.JPG g933571.jpg GRAPHIC 48468
  Complete submission text file 0001047469-19-000791.txt   7674235

Data Files

Seq Description Document Type Size
9 EX-101.INS espr-20181231.xml EX-101.INS 1651696
10 EX-101.SCH espr-20181231.xsd EX-101.SCH 43076
11 EX-101.CAL espr-20181231_cal.xml EX-101.CAL 52473
12 EX-101.LAB espr-20181231_lab.xml EX-101.LAB 462180
13 EX-101.PRE espr-20181231_pre.xml EX-101.PRE 313172
14 EX-101.DEF espr-20181231_def.xml EX-101.DEF 165920
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35986 | Film No.: 19644233
SIC: 2834 Pharmaceutical Preparations